Yogish Somayaji
Overview
Explore the profile of Yogish Somayaji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tom V, Jose A, Mallick S, Sasidharan A, Pawar R, Somayaji Y, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Mar;
PMID: 40063239
Cancer immunotherapy has long been an essential segment of current research and presents several problems to contemporary medicine. Though their precise roles are still elusive, recent studies have highlighted the...
2.
Yuan M, Han Z, Somayaji Y, Nguyen N, Hu H, Madhu L, et al.
Adv Compos Hybrid Mater
. 2025 Jan;
8(1):131.
PMID: 39834534
Dosage tolerance is one of the translational challenges of using metformin (Met) in brain therapeutics. This paper presents metal-organic framework (MOF)-74-Mg nanocarriers (NCs) for intranasal (IN) delivery of brain-specific agents...
3.
Kodali M, Madhu L, Somayaji Y, Attaluri S, Huard C, Panda P, et al.
Aging Cell
. 2024 Nov;
24(2):e14398.
PMID: 39571180
While moderately activated microglia in Alzheimer's disease (AD) are pivotal in clearing amyloid beta (Aβ), hyperactivated microglia perpetuate neuroinflammation. Prior investigations reported that the elimination of ~80% of microglia through...
4.
Madhu L, Kodali M, Upadhya R, Rao S, Somayaji Y, Attaluri S, et al.
J Extracell Vesicles
. 2024 Nov;
13(11):e12519.
PMID: 39499013
As current treatments for Alzheimer's disease (AD) lack disease-modifying interventions, novel therapies capable of restraining AD progression and maintaining better brain function have great significance. Anti-inflammatory extracellular vesicles (EVs) derived...
5.
Kodali M, Madhu L, Kolla V, Attaluri S, Huard C, Somayaji Y, et al.
Mil Med Res
. 2024 Aug;
11(1):61.
PMID: 39169440
Background: Chronic Gulf War Illness (GWI) is characterized by cognitive and mood impairments, as well as persistent neuroinflammation and oxidative stress. This study aimed to investigate the efficacy of Epidiolex,...
6.
Kodali M, Madhu L, Somayaji Y, Attaluri S, Huard C, Panda P, et al.
bioRxiv
. 2024 Jul;
PMID: 39071343
Chronic neuroinflammation represents a prominent hallmark of Alzheimer's disease (AD). While moderately activated microglia are pivotal in clearing amyloid beta (Aβ), hyperactivated microglia perpetuate neuroinflammation. Prior investigations have indicated that...
7.
Madhu L, Kodali M, Upadhya R, Rao S, Shuai B, Somayaji Y, et al.
bioRxiv
. 2024 Jan;
PMID: 38293018
Antiinflammatory extracellular vesicles (EVs) derived from human induced pluripotent stem cell (hiPSC)-derived neural stem cells (NSCs) hold promise as a disease-modifying biologic for Alzheimer's disease (AD). This study directly addressed...
8.
Ayyubova G, Kodali M, Upadhya R, Madhu L, Attaluri S, Somayaji Y, et al.
J Neuroinflammation
. 2023 Dec;
20(1):297.
PMID: 38087314
Extracellular vesicles (EVs) released by human induced pluripotent stem cell-derived neural stem cells (hiPSC-NSCs) are enriched with miRNAs and proteins capable of mediating robust antiinflammatory activity. The lack of tumorigenic...
9.
Lewy K, Faccin M, Somayaji Y, Pursell K, Porter B, Vemulapalli T, et al.
J Comp Pathol
. 2023 Jan;
201:53-56.
PMID: 36709728
Reports of compound odontomas in rats are very rare. A 14-month-old adult male Sprague Dawley rat was found to have a hard mass associated with the caudal aspect of the...
10.
Madhu L, Somayaji Y, Shetty A
Ageing Res Rev
. 2022 May;
78:101637.
PMID: 35504553
Strategies proficient for relieving cognitive impairments in aging and Alzheimer's disease (AD) have an enormous impact. Regular physical exercise (PE) can prevent age-related dementia and slow down AD progression. However,...